×
Entrez Id: 5919
Gene Symbol: RARRES2
RARRES2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis.
23507574 2013
×
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
[Effect of electro-acupuncture on hepatic Toll-like receptor 4 and nuclear factor κB expressions in rats with non-alcoholic fatty liver disease].
25413054 2014
×
Entrez Id: 3156
Gene Symbol: HMGCR
HMGCR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
ModifyingMutation
RGD
An atherogenic diet decreases liver FXR gene expression and causes severe hepatic steatosis and hepatic cholesterol accumulation: effect of endurance training.
23117815 2013
PPARGC1A
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
21373642 2011
×
Entrez Id: 7099
Gene Symbol: TLR4
TLR4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
23301938 2013
×
Entrez Id: 9971
Gene Symbol: NR1H4
NR1H4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431 2014
×
Entrez Id: 10062
Gene Symbol: NR1H3
NR1H3
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431 2014
×
Entrez Id: 7351
Gene Symbol: UCP2
UCP2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region.
18543254 2008
×
Entrez Id: 23409
Gene Symbol: SIRT4
SIRT4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats.
20651844 2010
×
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis.
22112382 2012
×
Entrez Id: 2936
Gene Symbol: GSR
GSR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.
24622831 2014
×
Entrez Id: 7124
Gene Symbol: TNF
TNF
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet.
19034968 2008
×
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
25317811 2014
×
Entrez Id: 3643
Gene Symbol: INSR
INSR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
SusceptibilityMutation
RGD
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
28468951 2017
×
Entrez Id: 1728
Gene Symbol: NQO1
NQO1
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway.
28932253 2017
×
Entrez Id: 3156
Gene Symbol: HMGCR
HMGCR
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431 2014
×
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
23592516 2013
×
Entrez Id: 9971
Gene Symbol: NR1H4
NR1H4
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models.
30257410 2018
×
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593 2017
×
Entrez Id: 27141
Gene Symbol: CIDEB
CIDEB
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431 2014
×
Entrez Id: 4023
Gene Symbol: LPL
LPL
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin.
30214514 2018
×
Entrez Id: 64240
Gene Symbol: ABCG5
ABCG5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Impaired VLDL assembly: a novel mechanism contributing to hepatic lipid accumulation following ovariectomy and high-fat/high-cholesterol diets?
25263431 2014
×
Entrez Id: 3240
Gene Symbol: HP
HP
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein.
21806828 2011
×
Entrez Id: 5445
Gene Symbol: PON2
PON2
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.
22536512 2012
×
Entrez Id: 60
Gene Symbol: ACTB
ACTB
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Biomarker
RGD
Protein carbonylation associated to high-fat, high-sucrose diet and its metabolic effects.
25282656 2014